NCT01979445 - Cangrelor to Clopidogrel or Prasugrel Transition Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 2, 2013

Primary Completion Date

January 20, 2014

Study Completion Date

January 20, 2014

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG

Cangrelor

Cangrelor intravenously (IV) administered as a 30 microgram (µg)/kilogram (kg) bolus, followed by 4 µg/kg/min infusion for 2 hrs on Day 1.

DRUG

Clopidogrel

Clopidogrel 600 mg single oral dose

DRUG

Prasugrel

Prasugrel 60 mg single oral dose

Trial Locations (1)

Fletcher Allen Health Care, Burlington